Free provider profile
STEPHEN ROHRER, CNP
WYNNE, AR
Find similar providers: Nurse Practitioner, Primary Care in WYNNE, AR
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
870-587-0800
Fax
870-587-0799
Practice address
1920 FALLS BLVD N, WYNNE, AR, 72396
- Registry updated
- 2024-12-20
- NPI issued
- 2016-11-02
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Nurse Practitioner, Primary Care
363LP2300X
PrimaryNurse Practitioner, Acute Care
363LA2100X
2 registered practice locations · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like STEPHEN ROHRER?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What STEPHEN ROHRER prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Mounjaro
- Jardiance
- Ozempic
- Trelegy Ellipta
- Santyl
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
6,185
Medicare patients
445
Part D drug cost
$810,841
Brand-name share
14.2%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Mounjaro (Tirzepatide) | 92 | $104,977 |
| Jardiance (Empagliflozin) | 78 | $59,719 |
| Ozempic (Semaglutide) | 53 | $51,324 |
| Santyl (Collagenase Clostridium Hist.) | 40 | $50,830 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | 48 | $41,111 |
| Eliquis (Apixaban) | 31 | $23,589 |
| Xarelto (Rivaroxaban) | 21 | $23,057 |
| Farxiga (Dapagliflozin Propanediol) | 30 | $22,334 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across AR — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
